174 related articles for article (PubMed ID: 21044842)
21. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.
Terzioglu N; van Rijn RM; Bakker RA; De Esch IJ; Leurs R
Bioorg Med Chem Lett; 2004 Nov; 14(21):5251-6. PubMed ID: 15454206
[TBL] [Abstract][Full Text] [Related]
22. Luciferase reporter gene assay on human, murine and rat histamine H4 receptor orthologs: correlations and discrepancies between distal and proximal readouts.
Nordemann U; Wifling D; Schnell D; Bernhardt G; Stark H; Seifert R; Buschauer A
PLoS One; 2013; 8(9):e73961. PubMed ID: 24023919
[TBL] [Abstract][Full Text] [Related]
23. Discovery of quinazolines as histamine H4 receptor inverse agonists using a scaffold hopping approach.
Smits RA; de Esch IJ; Zuiderveld OP; Broeker J; Sansuk K; Guaita E; Coruzzi G; Adami M; Haaksma E; Leurs R
J Med Chem; 2008 Dec; 51(24):7855-65. PubMed ID: 19053770
[TBL] [Abstract][Full Text] [Related]
24. Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
Xie SX; Ghorai P; Ye QZ; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2006 Apr; 317(1):139-46. PubMed ID: 16394198
[TBL] [Abstract][Full Text] [Related]
25. The histamine H₄ receptor: targeting inflammatory disorders.
Walter M; Kottke T; Stark H
Eur J Pharmacol; 2011 Oct; 668(1-2):1-5. PubMed ID: 21741967
[TBL] [Abstract][Full Text] [Related]
26. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
[TBL] [Abstract][Full Text] [Related]
27. INCB38579, a novel and potent histamine H₄ receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functions.
Shin N; Covington M; Bian D; Zhuo J; Bowman K; Li Y; Soloviev M; Qian DQ; Feldman P; Leffet L; He X; He Wang K; Krug K; Bell D; Czerniak P; Hu Z; Zhao H; Zhang J; Yeleswaram S; Yao W; Newton R; Scherle P
Eur J Pharmacol; 2012 Jan; 675(1-3):47-56. PubMed ID: 22155710
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.
Govoni M; Bakker RA; van de Wetering I; Smit MJ; Menge WM; Timmerman H; Elz S; Schunack W; Leurs R
J Med Chem; 2003 Dec; 46(26):5812-24. PubMed ID: 14667234
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and histamine H(3) and H(4) receptor activity of conformationally restricted cyanoguanidines related to UR-PI376.
Geyer R; Buschauer A
Arch Pharm (Weinheim); 2011 Dec; 344(12):775-85. PubMed ID: 21987304
[TBL] [Abstract][Full Text] [Related]
30. The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists.
Hancock AA
Biochem Pharmacol; 2006 Apr; 71(8):1103-13. PubMed ID: 16513092
[TBL] [Abstract][Full Text] [Related]
31. Delineation of agonist binding to the human histamine H4 receptor using mutational analysis, homology modeling, and ab initio calculations.
Jongejan A; Lim HD; Smits RA; de Esch IJ; Haaksma E; Leurs R
J Chem Inf Model; 2008 Jul; 48(7):1455-63. PubMed ID: 18553960
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and structural and pharmacological properties of cyclopropane-based conformationally restricted analogs of 4-methylhistamine as histamine H3/H4 receptor ligands.
Kobayashi T; Watanabe M; Yoshida A; Yamada S; Ito M; Abe H; Ito Y; Arisawa M; Shuto S
Bioorg Med Chem; 2010 Feb; 18(3):1076-82. PubMed ID: 20045649
[TBL] [Abstract][Full Text] [Related]
33. Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies.
Lim HD; Istyastono EP; van de Stolpe A; Romeo G; Gobbi S; Schepers M; Lahaye R; Menge WM; Zuiderveld OP; Jongejan A; Smits RA; Bakker RA; Haaksma EE; Leurs R; de Esch IJ
Bioorg Med Chem; 2009 Jun; 17(11):3987-94. PubMed ID: 19414267
[TBL] [Abstract][Full Text] [Related]
34. The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists.
Birnkammer T; Spickenreither A; Brunskole I; Lopuch M; Kagermeier N; Bernhardt G; Dove S; Seifert R; Elz S; Buschauer A
J Med Chem; 2012 Feb; 55(3):1147-60. PubMed ID: 22216892
[TBL] [Abstract][Full Text] [Related]
35. No evidence for functional selectivity of proxyfan at the human histamine H3 receptor coupled to defined Gi/Go protein heterotrimers.
Schnell D; Burleigh K; Trick J; Seifert R
J Pharmacol Exp Ther; 2010 Mar; 332(3):996-1005. PubMed ID: 19959746
[TBL] [Abstract][Full Text] [Related]
36. Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligands.
Engelhardt H; de Esch IJ; Kuhn D; Smits RA; Zuiderveld OP; Dobler J; Mayer M; Lips S; Arnhof H; Scharn D; Haaksma EE; Leurs R
Eur J Med Chem; 2012 Aug; 54():660-8. PubMed ID: 22749391
[TBL] [Abstract][Full Text] [Related]
37. Molecular determinants for the high constitutive activity of the human histamine H4 receptor: functional studies on orthologues and mutants.
Wifling D; Löffel K; Nordemann U; Strasser A; Bernhardt G; Dove S; Seifert R; Buschauer A
Br J Pharmacol; 2015 Feb; 172(3):785-98. PubMed ID: 24903527
[TBL] [Abstract][Full Text] [Related]
38. Development of a homogeneous binding assay for histamine receptors.
Crane K; Shih DT
Anal Biochem; 2004 Dec; 335(1):42-9. PubMed ID: 15519569
[TBL] [Abstract][Full Text] [Related]
39. The first potent and selective non-imidazole human histamine H4 receptor antagonists.
Jablonowski JA; Grice CA; Chai W; Dvorak CA; Venable JD; Kwok AK; Ly KS; Wei J; Baker SM; Desai PJ; Jiang W; Wilson SJ; Thurmond RL; Karlsson L; Edwards JP; Lovenberg TW; Carruthers NI
J Med Chem; 2003 Sep; 46(19):3957-60. PubMed ID: 12954048
[TBL] [Abstract][Full Text] [Related]
40. Molecular basis for the selective interaction of synthetic agonists with the human histamine H1-receptor compared with the guinea pig H1-receptor.
Strasser A; Wittmann HJ; Kunze M; Elz S; Seifert R
Mol Pharmacol; 2009 Mar; 75(3):454-65. PubMed ID: 19047480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
